Showing results (351-360 of 513) with videos related to
Sort By:
Pageof 52
Biochemical and Biophysical Research Communications|November 29, 2023
Fatty acid elongation regulates mitochondrial β-oxidation and cell viability in prostate cancer by controlling malonyl-CoA levelsJulia S Scott, Lake-Ee Quek, Andrew J Hoy, et al.Journal of the American Dietetic Association|September 25, 2004
Changes in dietary intake after diagnosis of breast cancerSharon J Wayne, Susan T Lopez, Lisa M Butler, et al.Tropical Medicine & International Health : TM & IH|November 25, 2010
Disease profile of children under 5 years attending primary health care clinics in a high HIV prevalence setting in South AfricaChristiane Horwood, Lisa M Butler, Kerry Vermaak, et al.JMIR Mhealth and Uhealth|February 19, 2021
Implementation of a Newborn Clinical Decision Support Software (NoviGuide) in a Rural District Hospital in Eastern Uganda: Feasibility and Acceptability StudyMary Muhindo, Joshua Bress, Rogers Kalanda, et al.Molecular Cancer Research : MCR|August 1, 2014
Altered endosome biogenesis in prostate cancer has biomarker potentialIan R D Johnson, Emma J Parkinson-Lawrence, Tetyana Shandala, et al.Nature Communications|November 12, 2015
Targeted drug delivery using genetically engineered diatom biosilicaBahman Delalat, Vonda C Sheppard, Soraya Rasi Ghaemi, et al.ACS Applied Materials & Interfaces|January 13, 2025
Triple-Negative Breast Cancer Aptamer-Targeting Porous Silicon NanocarrierAnkit Malhotra, Pouya Dehghankelishadi, Ishdeep Kaur, et al.African Journal of AIDS Research : AJAR|October 26, 2018
Courage and confidence to stop lying: caregiver perspectives on a video to support paediatric HIV disclosure in Kampala, UgandaSonja Klingberg, Rachel King, Janet Seeley, et al.Molecular and Cellular Endocrinology|March 6, 2007
Uncoupling of hormone-dependence from chaperone-dependence in the L701H mutation of the androgen receptorKenneth Robzyk, Handy Oen, Grant Buchanan, et al.Proceedings of the National Academy of Sciences of the United States of America|August 22, 2002
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxinLisa M Butler, Xianbo Zhou, Wei-Sheng Xu, et al.Pageof 52